These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 12175684

  • 1. Farnesyl transferase inhibitors as anticancer agents.
    Haluska P, Dy GK, Adjei AA.
    Eur J Cancer; 2002 Sep; 38(13):1685-700. PubMed ID: 12175684
    [Abstract] [Full Text] [Related]

  • 2. Farnesyl transferase inhibitors: a major breakthrough in anticancer therapy? Naples, 12 April 2002.
    Caponigro F.
    Anticancer Drugs; 2002 Sep; 13(8):891-7. PubMed ID: 12394276
    [Abstract] [Full Text] [Related]

  • 3. Farnesyl transferase inhibitors in the treatment of breast cancer.
    Kelland LR.
    Expert Opin Investig Drugs; 2003 Mar; 12(3):413-21. PubMed ID: 12605564
    [Abstract] [Full Text] [Related]

  • 4. Preclinical and clinical evaluation of farnesyltransferase inhibitors.
    Baum C, Kirschmeier P.
    Curr Oncol Rep; 2003 Mar; 5(2):99-107. PubMed ID: 12583826
    [Abstract] [Full Text] [Related]

  • 5. [Farnesyltransferase inhibitors: preliminary results in acute myeloid leukemia].
    Thomas X, Elhamri M.
    Bull Cancer; 2005 Mar; 92(3):227-38. PubMed ID: 15820917
    [Abstract] [Full Text] [Related]

  • 6. Farnesyltransferase inhibitors.
    Hahn SM, Bernhard E, McKenna WG.
    Semin Oncol; 2001 Oct; 28(5 Suppl 16):86-93. PubMed ID: 11706400
    [Abstract] [Full Text] [Related]

  • 7. Farnesyl protein transferase inhibition: a novel approach to anti-tumor therapy. the discovery and development of SCH 66336.
    Ganguly AK, Doll RJ, Girijavallabhan VM.
    Curr Med Chem; 2001 Oct; 8(12):1419-36. PubMed ID: 11562275
    [Abstract] [Full Text] [Related]

  • 8. Farnesyl transferase inhibitors in myeloid malignancies.
    Lancet JE, Karp JE.
    Blood Rev; 2003 Sep; 17(3):123-9. PubMed ID: 12818222
    [Abstract] [Full Text] [Related]

  • 9. Farnesyltransferase inhibitors and their potential in the treatment of breast carcinoma.
    de Bono JS, Tolcher AW, Rowinsky EK.
    Semin Oncol; 2003 Oct; 30(5 Suppl 16):79-92. PubMed ID: 14613029
    [Abstract] [Full Text] [Related]

  • 10. [Farnesyl transferase inhibitors--a novel agent for breast cancer].
    Zhang M, Jiang D.
    Ai Zheng; 2006 Apr; 25(4):516-20. PubMed ID: 16613692
    [Abstract] [Full Text] [Related]

  • 11. Farnesyl transferase inhibitors for patients with lung cancer.
    Johnson BE, Heymach JV.
    Clin Cancer Res; 2004 Jun 15; 10(12 Pt 2):4254s-4257s. PubMed ID: 15217969
    [Abstract] [Full Text] [Related]

  • 12. [Development of farsenyl transferase inhibitors as anticancer agents].
    Cestac P, Doisneau-Sixou S, Favre G.
    Ann Pharm Fr; 2005 Jan 15; 63(1):76-84. PubMed ID: 15803104
    [Abstract] [Full Text] [Related]

  • 13. Farnesyltransferase inhibitors--a novel approach in the treatment of advanced pancreatic carcinomas.
    Dempke WC.
    Anticancer Res; 2003 Jan 15; 23(2A):813-8. PubMed ID: 12820305
    [Abstract] [Full Text] [Related]

  • 14. Agents targeting ras signaling pathway.
    Dancey JE.
    Curr Pharm Des; 2002 Jan 15; 8(25):2259-67. PubMed ID: 12369854
    [Abstract] [Full Text] [Related]

  • 15. Clinical activity of farnesyl transferase inhibitors in hematologic malignancies: possible mechanisms of action.
    Jabbour E, Kantarjian H, Cortes J.
    Leuk Lymphoma; 2004 Nov 15; 45(11):2187-95. PubMed ID: 15512806
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Ras biochemistry and farnesyl transferase inhibitors: a literature survey.
    Crul M, de Klerk GJ, Beijnen JH, Schellens JH.
    Anticancer Drugs; 2001 Mar 15; 12(3):163-84. PubMed ID: 11290863
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Farnesyltransferase and geranylgeranyltransferase I inhibitors and cancer therapy: lessons from mechanism and bench-to-bedside translational studies.
    Sebti SM, Hamilton AD.
    Oncogene; 2000 Dec 27; 19(56):6584-93. PubMed ID: 11426643
    [Abstract] [Full Text] [Related]

  • 20. [Ras signaling pathway as a target for farnesyltransferase inhibitors--a new, promising prospects in the treatment for malignant disorders].
    Helbig G, Hołowiecki J.
    Wiad Lek; 2004 Dec 27; 57(9-10):462-7. PubMed ID: 15765763
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.